Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 16/20 | 0.58 |
| ▸ | BACE2 | Q9Y5Z0 | 4/20 | 0.58 |
| ▸ | CTSD | P07339 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16508506 | 0.90 | BACE1 (0.53) | BACE1BACE2CTSD | |
| SCHEMBL16508536 | 0.88 | ALDH1A1 (0.54) | BACE1BACE2CTSD | |
| SCHEMBL6377734 | 0.85 | BACE1 (0.61) | BACE1BACE2CTSD | |
| SCHEMBL6377728 | 0.85 | BACE1 (0.61) | BACE1BACE2CTSD | |
| SCHEMBL30903463 | 0.85 | BACE1 (0.67) | BACE1BACE2CTSD | |
| SCHEMBL31307282 | 0.83 | BACE1 (0.58) | BACE1BACE2CTSD | |
| SCHEMBL29939570 | 0.83 | OPRM1 (0.56) | BACE1BACE2 | |
| SCHEMBL30312074 | 0.83 | BACE1 (0.55) | BACE1BACE2CTSD | |
| SCHEMBL29772150 | 0.82 | BACE1 (0.62) | BACE1BACE2CTSD | |
| SCHEMBL29860241 | 0.82 | OPRM1 (0.60) | BACE1BACE2CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110300167-A1 | CXCR5 RECEPTOR COMPOUNDS | ANCHOR THERAPEUTICS, INC. | 2011-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110300167-A1 | CXCR5 RECEPTOR COMPOUNDS | CXCR5, CXCR1, CCR5 | BACE1 3391/4885BACE2 3865/4885CTSD 3756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.